STOCK TITAN

Israel Corp. Reports Results for Fourth Quarter of 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

Israel Corporation Ltd. (TASE: ILCO) announced its fourth-quarter and annual results for 2022, ending December 31. Key figures include a net profit from continuing activities of $132 million in Q4 2022, compared to $110 million in Q4 2021, and an annual net profit of $871 million, up from $269 million in 2021. The company reported total financial liabilities of $1,132 million and investments in liquid assets of $982 million. Additionally, a dividend policy was approved, targeting a 45% distribution of cash flow received from held companies, subject to board approval. IC also completed a $64 million transaction related to Bazan shares.

Positive
  • Net profit from continuing activities increased to $132 million in Q4 2022 from $110 million in Q4 2021.
  • Annual net profit rose to $871 million in 2022, compared to $269 million in 2021.
  • Approval of a dividend policy distributing 45% of cash flow received from held companies.
Negative
  • Net profit to company's shareholders dropped from $160 million in Q4 2021 to $132 million in Q4 2022.
  • Total financial liabilities stand at $1,132 million, posing potential liquidity risks.

TEL AVIV, Israel, March 16, 2023 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("IC") announced today its fourth quarter and annual results for the period ending December 31, 2022.

Selected Financial Figures for the fourth Quarter and 2022:

$m

Q4/22

Q4/21

2022

2021

IC share in ICL profit

146

129

958

357

Amortization of excess cost

(1)

(1)

(4)

(4)

Financing, G&A and other expenses at IC headquarter level

(3)

(18)

(67)

(84)

Tax Expenses of IC Headquarters

(10)

-

(16)

-

Net Profit (loss) from continuing activities

132

110

871

269

Net Profit (loss) from discontinued operations[1]

-

50

50

(181)

Net Profit to company's shareholders

132

160

921

88

 

Debt Balances and Liquidity at the IC Headquarters Level[2]

As of December 31, 2022, total financial liabilities1 were $1,132 million, and investments in liquid assets amounted to $982 million of which $8 are pledged deposits.

Net debt1 as of December 31, 2022, totaled $179 million. The net debt includes the fair value of derivative transactions, which increases the economic value of the financial liabilities in the amount of $10 million, and the fair value of the Bazan call options3 which increases the economic value of the financial liabilities by $19m. As of September 30, 2022, the net debt1 was $234m.

Additional updates

In January 2023, IC announced that the Board of Directors approved the adoption of a dividend policy. IC will distribute dividend for each calendar year starting at 2023, amounting to 45% out of the amount received from: the total net dividend cash flow received from its held companies for that calendar year, less an annual amount of $75m (from the amount of said cash flow). The actual dividend distribution will be subject to IC Board approval.

Further to the IC's Reports regarding a transaction for the sale of approximately 9% of the shares of Bazan on November 2021 in which IC granted a call option to each of the purchasers, on February 9, 2023, agreement was reached with the purchasers regarding the exercise of the entirety of the said options, which was implemented on February 13, 2023, for approximately NIS 227m (equivalent to approximately US $64m)

On February 9, IC announced that subject to the completion of the sale of the underlying shares of the said options and the actual receipt of the consideration thereof by IC, the Board of Directors of IC intends to consider adopting a buyback plan for shares of the company during 2023 in a scope of approximately half of the amount of the consideration.

On March 3, 2023, IC completed an investment into Nordic Aqua Partners A/S, which is building an Atlantic Salmon land-based facility in China with AKVA as its technology provider, in an amount of NOK 89m (~$9m).

As a holding company, the financial results of IC are mainly affected by the results of its held companies. For more details see detailed financial report.

IC Total Assets, Net

$m

31/12/2022

Assets


ICL (~567m shares, market value[4],[5])

4,101

Bazan (~234m shares, market value[3])

65

Akva Group (market value)

39

Total Assets

4,204

IC's Net Debt

179

Total Assets, net

4,025

 

[1] For more details on the sale of 16.687% of Bazan shares please refer to IC Q3/2022 financial statements and immediate report dated September 15, 2022

[2] Israel Corp and its wholly owned and controlled headquarter companies.

[3] Relating to options granted to qualified investors as part of the November 2021 9% share sale and to options granted to Petrochemical Group as part of the Bazan ~16.7% stake sale in September 2022.

[4] As of December 29, 2022, for ICL and December 30, 2022, for AKVA Group.

[5]Based on the exercise price agreed by the company with the call options purchasers on February 9, 2023.

 

About Israel Corporation

Israel Corporation Ltd. (TASE: ILCO) ("IC") is a reputable public investment company, which owns and invests in high quality companies with established managements and go-to markets.

In November 2019, IC announced its updated strategy, IC plans to expand its portfolio through new investments over the next few years. IC plans to focus mainly on the food (inc. tech), agriculture (inc. tech), healthcare and industry 4.0 sectors. For more details please see the following link to IC updated Strategy Presentation

IC strives to generate return on its investment through active board participations and its operational and managerial expertise.

IC current core holdings include c.44% stake in ICL Group (NYSE:ICL, TASE:ICL) and c.18% stake in AKVA Group (OB:AKVA). IC is publicly traded on the Tel Aviv Stock Exchange under the ticker ILCO and is included in the TA-35 Index.

For further information on IC, see IC's publicly available filings, which can be found on the Tel Aviv Stock Exchange website at http://maya.tase.co.il.

Please also see IC company website http://www.israelcorp.com for additional information.

Convenience Translation

The financial information found in this press release is an English summary based on the original Hebrew financial statements and is solely for the convenience of the reader. The binding version is the original in Hebrew.

Forward Looking Statements

This press release may contain forward-looking statements, which may not materialize and are subject to risks and uncertainties that are not under the control of IC, which may cause actual results to differ materially from those contained in the disclosures.

 

Investor Relations Contact
Idan Hizki
Vice President, Business Development & Investor Relations
Tel: +972 3 684 4500
idanh@israelcorp.com

Cision View original content:https://www.prnewswire.com/news-releases/israel-corp-reports-results-for-fourth-quarter-of-2022-301774596.html

SOURCE Israel Corporation Ltd.

FAQ

What were Israel Corporation's fourth-quarter results for 2022?

Israel Corporation reported a net profit of $132 million for Q4 2022, up from $110 million in Q4 2021.

What is the annual net profit for Israel Corporation in 2022?

The annual net profit for Israel Corporation in 2022 reached $871 million, an increase from $269 million in 2021.

What is the new dividend policy for Israel Corporation?

Israel Corporation's new dividend policy allows a distribution of 45% of cash flow received from held companies, subject to board approval.

What are the total financial liabilities reported by Israel Corporation?

As of December 31, 2022, Israel Corporation reported total financial liabilities of $1,132 million.

What significant transaction did Israel Corporation complete in early 2023?

In February 2023, Israel Corporation completed a transaction regarding the sale of approximately 9% of Bazan shares for about $64 million.

ISRAEL CORP ORD

OTC:IRLCF

IRLCF Rankings

IRLCF Latest News

IRLCF Stock Data

1.88B
3.95M
51.21%
11.42%
Specialty Chemicals
Basic Materials
Link
United States of America
Tel Aviv